S. VURAL Et Al. , "ADALIMUMAB (HUMIRA®) INDUCED RECURRENT PERITONSILLAR ABSCESS IN A PATIENT WHO RECEIVED THREE DIFFERENT ANTI-TNF THERAPIES," 2021 - 17. Ulusal Acil Tıp Kongresi, 8th Intercontinental Emergency Medicine Congress, 8th International Critical Care and Emergency Medicine Congress , Antalya, Turkey, 2021
VURAL, S. Et Al. 2021. ADALIMUMAB (HUMIRA®) INDUCED RECURRENT PERITONSILLAR ABSCESS IN A PATIENT WHO RECEIVED THREE DIFFERENT ANTI-TNF THERAPIES. 2021 - 17. Ulusal Acil Tıp Kongresi, 8th Intercontinental Emergency Medicine Congress, 8th International Critical Care and Emergency Medicine Congress , (Antalya, Turkey).
VURAL, S., KUŞDOĞAN, M., İKİZ, V., ÇALTEKİN, İ., GÖKÇEN, E., & ALBAYRAK, L., (2021). ADALIMUMAB (HUMIRA®) INDUCED RECURRENT PERITONSILLAR ABSCESS IN A PATIENT WHO RECEIVED THREE DIFFERENT ANTI-TNF THERAPIES . 2021 - 17. Ulusal Acil Tıp Kongresi, 8th Intercontinental Emergency Medicine Congress, 8th International Critical Care and Emergency Medicine Congress, Antalya, Turkey
VURAL, SEVİLAY Et Al. "ADALIMUMAB (HUMIRA®) INDUCED RECURRENT PERITONSILLAR ABSCESS IN A PATIENT WHO RECEIVED THREE DIFFERENT ANTI-TNF THERAPIES," 2021 - 17. Ulusal Acil Tıp Kongresi, 8th Intercontinental Emergency Medicine Congress, 8th International Critical Care and Emergency Medicine Congress, Antalya, Turkey, 2021
VURAL, SEVİLAY Et Al. "ADALIMUMAB (HUMIRA®) INDUCED RECURRENT PERITONSILLAR ABSCESS IN A PATIENT WHO RECEIVED THREE DIFFERENT ANTI-TNF THERAPIES." 2021 - 17. Ulusal Acil Tıp Kongresi, 8th Intercontinental Emergency Medicine Congress, 8th International Critical Care and Emergency Medicine Congress , Antalya, Turkey, 2021
VURAL, S. Et Al. (2021) . "ADALIMUMAB (HUMIRA®) INDUCED RECURRENT PERITONSILLAR ABSCESS IN A PATIENT WHO RECEIVED THREE DIFFERENT ANTI-TNF THERAPIES." 2021 - 17. Ulusal Acil Tıp Kongresi, 8th Intercontinental Emergency Medicine Congress, 8th International Critical Care and Emergency Medicine Congress , Antalya, Turkey.
@conferencepaper{conferencepaper, author={SEVİLAY VURAL Et Al. }, title={ADALIMUMAB (HUMIRA®) INDUCED RECURRENT PERITONSILLAR ABSCESS IN A PATIENT WHO RECEIVED THREE DIFFERENT ANTI-TNF THERAPIES}, congress name={2021 - 17. Ulusal Acil Tıp Kongresi, 8th Intercontinental Emergency Medicine Congress, 8th International Critical Care and Emergency Medicine Congress}, city={Antalya}, country={Turkey}, year={2021}}